{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-035863","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2023-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.408870+00:00","generated_at":"2026-06-13T04:04:25.610594+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Board adds Lorinda Burgess; director equity grants fully vested","bullets":["Lorinda Burgess appointed as Class III director effective July 19, 2023, expanding board to nine members.","Burgess brings 35+ years experience, including 15+ years at Medtronic as Vice President of Finance, Americas Region.","Burgess was appointed to the Audit Committee and Compensation Committee of the Board.","Non-employee director annual equity grants changed to be fully vested at time of grant."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-035863","json":"https://secwatch.observer/filing/0001140361-23-035863.json","markdown":"https://secwatch.observer/filing/0001140361-23-035863.md","text":"https://secwatch.observer/filing/0001140361-23-035863.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035863/0001140361-23-035863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035863/brhc20056191_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:04:25.610594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2d1bf5231e","claim":"Lorinda Burgess was appointed as Class III Director at ANGIODYNAMICS INC.","evidence_excerpt":"On July 19, 2023, the board of directors (the “Board”) of AngioDynamics, Inc. (“AngioDynamics”) approved an increase in the size of the Board to a total of nine directors and appointed Lorinda Burgess as a Class III director of AngioDynamics, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035863/0001140361-23-035863-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}